Motivational Interviewing works, but no better than other treatments

Cochrane conducts a meta-analysis of motivational interviewing (MI) and concludes that it's no more effective than other treatments. More than 76 million people worldwide have alcohol problems, and another 15 million have drug problems. Motivational interviewing (MI) is a psychological treatment that aims to help people cut down or stop using drugs and alcohol. The … Continue reading Motivational Interviewing works, but no better than other treatments

Response to Why Addiction is NOT a Brain Disease

In a thoughtful post, Marc Lewis questions the disease model of addiction. He doesn't dismiss it out of hand. He seems to look for ways in which it's right and useful. It’s accurate in some ways. It accounts for the neurobiology of addiction better than the “choice” model and other contenders. It explains the helplessness … Continue reading Response to Why Addiction is NOT a Brain Disease

Suboxone Strategy: Protecting Patients Or Profits?

I'm a little late on posting this one, but it still seems worth sharing. Reckitt Benckiser has decided to pull Suboxone tablets from the market. Why? It's an evidence-based decision and an expression of their desire to be a good corporate citizen and their concern for children. Late last month, Reckitt Benckiser created a stir … Continue reading Suboxone Strategy: Protecting Patients Or Profits?

Another Reaction to Hazelden’s Adoption of Suboxone

Mark Willenbring, a former Director of the Treatment and Recovery Research Division of the National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health weighs in on Hazelden's embrace of Suboxone Hazelden's new approach is a seismic shift that is likely to move the entire industry in this direction. I told Marv that it was like … Continue reading Another Reaction to Hazelden’s Adoption of Suboxone

NAATP launches counteroffensive to medication push

This is very welcome news: Frustrated that medication-assisted treatment is coming across as the addiction field’s standard of care simply because drug company studies are dominating the research landscape, a group of some of the most prominent leaders in treatment administration is vowing to fight back. These leaders have enlisted the help of another heavy … Continue reading NAATP launches counteroffensive to medication push

Hazelden to start opioid maintenance

This has gotten a lot of attention [emphasis mine]: ...for the first time, Hazelden will begin providing medication-assisted treatment for people hooked on heroin or opioid painkillers, starting at its Center City, Minnesota facility and expanding across its treatment network in five states in 2013.  This so-called maintenance therapy differs from simply detoxifying addicts until … Continue reading Hazelden to start opioid maintenance

The social cost of smoking

  Apparently, Singapore was an early adopter of designated smoking areas and non-smoking areas. However, this wasn't driven by health concerns. Rather, it was driven by aesthetic concerns--primarily smell. In a fascinating paper published recently in Urban Studies, Qian Hui Tan observes that smokers are "purveyors of sensory pollution" – creating a scent that, like all odors, … Continue reading The social cost of smoking